KKR & CO ($KKR) posted quarterly earnings results on Thursday, May 1st. The company reported earnings of $1.15 per share, missing estimates of $1.17 by $0.02. The company also reported revenue of $1,200,120,000, missing estimates of $1,761,333,445 by $-561,213,445.
You can see Quiver Quantitative's $KKR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
KKR & CO Hedge Fund Activity
We have seen 638 institutional investors add shares of KKR & CO stock to their portfolio, and 543 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 4,601,415 shares (-11.6%) from their portfolio in Q4 2024, for an estimated $680,595,292
- NUVEEN ASSET MANAGEMENT, LLC added 3,391,581 shares (+106.2%) to their portfolio in Q4 2024, for an estimated $501,648,745
- BLACKROCK, INC. added 2,794,200 shares (+6.3%) to their portfolio in Q4 2024, for an estimated $413,290,122
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,342,728 shares (-85.1%) from their portfolio in Q4 2024, for an estimated $346,512,898
- GQG PARTNERS LLC added 2,202,368 shares (+inf%) to their portfolio in Q4 2024, for an estimated $325,752,250
- VULCAN VALUE PARTNERS, LLC removed 1,851,795 shares (-99.9%) from their portfolio in Q4 2024, for an estimated $273,898,998
- PROFICIO CAPITAL PARTNERS LLC added 1,542,092 shares (+4981.9%) to their portfolio in Q4 2024, for an estimated $228,090,827
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KKR & CO Government Contracts
We have seen $1,193,196 of award payments to $KKR over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- GMP MANUFACTURING OF CDC FLUSC2 MULTIPLEX EUAAND IVD KITS: $763,453
- PCR TESTING KITS: $249,997
- BIOSEARCH BPA 499 YERSONIA PESTIS, 4 PER KIT: $116,780
- DLO-FB1-2 DUAL-LABELED PROBE, 5' FAM/3': $62,965
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
KKR & CO Congressional Stock Trading
Members of Congress have traded $KKR stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $KKR stock by members of Congress over the last 6 months:
- REPRESENTATIVE JOSH GOTTHEIMER has traded it 3 times. They made 1 purchase worth up to $15,000 on 11/19 and 2 sales worth up to $30,000 on 02/27, 02/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
KKR & CO Analyst Ratings
Wall Street analysts have issued reports on $KKR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HSBC issued a "Buy" rating on 04/15/2025
- Wells Fargo issued a "Overweight" rating on 03/20/2025
- Wolfe Research issued a "Outperform" rating on 01/03/2025
To track analyst ratings and price targets for KKR & CO, check out Quiver Quantitative's $KKR forecast page.
KKR & CO Price Targets
Multiple analysts have issued price targets for $KKR recently. We have seen 3 analysts offer price targets for $KKR in the last 6 months, with a median target of $141.0.
Here are some recent targets:
- Vikram Gandhi from HSBC set a target price of $119.0 on 04/15/2025
- An analyst from Wells Fargo set a target price of $141.0 on 03/20/2025
- Steven Chubak from Wolfe Research set a target price of $185.0 on 01/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
